Position:
Vice President of CRO Business Unit at PharmaBlock Group
Location:
Nanjing, Jiangsu, China
Found email addresses for Jin Li:
Found phone for Jin Li:
May 2026 - Current
Jun 2023 - May 2026
Mar 2021 - Jun 2023
Jan 2017 - Mar 2021
Jan 2009 - Jan 2017
Their professional focus is Autoimmune Diseases, FBDD-enabled PROTAC discovery, and Fragment-based drug discovery (FBDD) across 3 core areas.
Jin has registered patents, including "Imidazole derivatives as indoleamine 2,3-dioxygenase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases, Inhibitors of protein arginine methyltransferase 5 (PRMT5), pharmaceutical products thereof, and methods thereof, and Method for synthesis of 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-formamidine hydrochloride".
Bachelor’s Degree at Nanjing University
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.